E-Scape Bio

E-Scape Bio

E-Scape Bio is developing small molecule therapeutics for neurodegenerative diseases that result from dysfunctional protein structure. Their lead program targets Apolipoprotein E4 (ApoE4), a variant of ApoE that is known to be a major genetic risk factor for Alzheimer’s disease.

<< Portfolio